SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

C4 Therapeutics Q3 EPS $(17.55) Down From $(8.93) YoY, Sales $8.45M Up From $5.36M YoY

C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(17.55) per share. This is a 96.53 percent decrease over losses of $(8.93) per share from the same period last year. The company reported $8.45 million in

· 11/12/2020 16:08
C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(17.55) per share. This is a 96.53 percent decrease over losses of $(8.93) per share from the same period last year. The company reported $8.45 million in sales this quarter. This is a 57.48 percent increase over sales of $5.36 million the same period last year.